Skip to main content

Cboe Global Markets, Inc.

For the period ended Sep 30, 2026. Filed Oct 30, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 30, 2026

CBOE$353.27+0.1%Stored close · as of Nov 6, 2026

What changed in Management’s Discussion and Analysis?

Read the current filing

Previous report: 10-Q

Period ended 2026-06-30; filed 2026-07-31.

0001628280-26-051239

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Current report: 10-Q

Period ended 2026-09-30; filed 2026-10-30.

0001628280-26-068447

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 255 previous paragraphs and 269 current paragraphs.

146 unchanged; 92 reworded; 29 added; 14 removed; 3 previous and 2 current paragraphs rearranged.

Tables are not compared: 25 previous and 26 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (29)

Current report

S&P Dow Jones Indices Exclusive Licensing Agreement Extension

Current report

On September 29, 2026, the Company announced a 25-year extension of its exclusive licensing agreement with S&P Dow Jones Indices (“S&P DJI”) that will continue the longstanding collaboration through 2051. Under the agreement, the Company will continue to have the exclusive rights to offer trading in its flagship SPX options. The Company and S&P DJI may also collaborate to pursue innovation beyond traditional index derivatives, including new products like tokenized options contracts.

Current report

Impairment of assets consists of charges to impair indefinite or long-lived assets if the carrying value exceeds the fair value.

Current report

Gain on divestiture, net represents the net gain recognized upon the sale of our Cboe Australia business to TMX, and primarily consists of the excess of sale proceeds over the net carrying value of the assets and liabilities disposed of, the reclassification of related accumulated foreign currency translation adjustments from other comprehensive income, and transaction and other closing-related costs.

Current report

(1)Organic net revenue is defined as revenues less cost of revenues excluding revenues less cost of revenues of any

Current report

acquisition that has occurred in the last year or any divestiture. Revenues less cost of revenues from acquisitions that have occurred more than one year ago are considered organic and are no longer excluded from organic net revenue from either period for comparative purposes. A reconciliation of organic net revenue to revenues less cost of revenues is included in the reconciliations that follow.

Current report

The following is a reconciliation of revenues less cost of revenues (“net revenue”) to organic net revenue (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively:

Current report

The following is a reconciliation of operating income to operating EBITDA and adjusted operating EBITDA by segment (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively (continued from previous page):

Current report

(c) This amount represents the net gain recognized upon the sale of our Cboe Australia business to TMX Group Limited.

Current report

(d) This amount represents an incremental reserve for collectability related to the Company's notes receivable in connection with the funding of the Consolidated Audit Trail, which is included in other expenses on the condensed consolidated statements of income.

Current report

The following summarizes changes in certain operational and financial metrics for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025:

Current report

Total cost of revenues increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in regulatory fees cost of revenues due to an increase in volumes traded on the Cboe U.S. equity and options exchanges, coupled with an increase in royalty fees due to increased volumes on Cboe options exchanges and an increase in liquidity payments primarily due to pricing changes implemented in 2025 on Cboe U.S. equity exchanges.

Current report

Regulatory fees cost of revenues increased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in the Section 31 fee rate, from an average rate of $0 per million dollars of covered sales for the three months ended September 30, 2025 to an average rate of $20.60 per million dollars of covered sales for the three months ended September 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees cost of revenues increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in volumes traded on the Cboe U.S. equity and options exchanges, partially offset by a decrease in the Section 31 fee rate, from an average rate of $13.68 per million dollars of covered sales for the nine months ended September 30, 2025 to an average rate of $13.52 per million dollars of covered sales for the nine months ended September 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Current report

Total operating expenses for the three months ended September 30, 2026 compared to the same period in 2025 increased $14.2 million, or 6%, primarily due to an increase in other expenses, compensation and benefits, and professional fees and outside services, partially offset by a decrease in travel and promotional expenses, depreciation and amortization, and impairment of assets. Total operating expenses for the nine months ended September 30, 2026 compared to the same period in 2025 increased $33.6 million, or 5%, primarily due to an increase in compensation and benefits and other expenses, partially offset by a decrease in impairment of assets and depreciation and amortization.

Current report

Technology support services increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to increases in cloud services expenses, artificial intelligence expenses, software licenses and subscriptions, and hardware maintenance, partially offset by decreases in network and phone connectivity expenses and software maintenance.

Current report

Travel and promotional expenses decreased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to decreases in marketing and advertising expenses and special events.

Current report

Impairment of assets decreased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to the impairment of Cboe Japan's assets of $4.5 million during the three months ended September 30, 2025 as a result of the wind down of the Company's Japanese equities business, partially offset by the impairment of intangible assets charge of $1.4 million associated with FT Options and Trade Alert as a result of the wind down of operations during the three months ended September 30, 2026.

Current report

Impairment of assets decreased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to the impairment of Cboe Japan's assets of $21.6 million during the nine months ended September 30, 2025 as a result of the wind down of the Company's Japanese equities business, partially offset by the impairment of intangible assets charge of $1.4 million associated with FT Options and Trade Alert as a result of the wind down of operations during the nine months ended September 30, 2026.

Current report

Gain on divestiture, net increased for the three and nine months ended September 30, 2026 compared to the same periods in 2025 due to the Company's sale of Cboe Australia to TMX, which closed in July 2026.

Current report

Earnings on investments, net decreased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to a $37.0 million decrease in the gains on the Company's former investment in 7Ridge Fund, which is fully exited as of September 30, 2026, partially offset by a $4.9 million increase on the Company's various minority investments net gains.

Current report

Revenues less cost of revenues increased $10.0 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 primarily due to an increase in net transaction and clearing fees driven by a 51% increase in net capture per one hundred touched shares, coupled with an increase in access and capacity fees. For the three months ended September 30, 2026, operating income for the North American Equities segment increased $7.1 million compared to the three months ended September 30, 2025 primarily due to an increase in revenues less cost of revenues, partially offset by an increase in operating expenses. Operating expenses increased $2.9 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 primarily due to an increase in other expenses related to an incremental reserve for collectability related to the Company's notes receivable in connection with the funding of the CAT, partially offset by decreases in compensation and benefits, depreciation and amortization, and professional fees and outside services.

Current report

Revenues less cost of revenues increased $39.4 million for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 primarily due to an increase in net transaction and clearing fees driven by a 15% increase in Cboe European Equities matched ADNV and a 21% increase in Cboe Clear Europe net settlement volume, coupled with an increase in other revenue due to an increase in operating interest income driven primarily by higher average daily cash balances at Cboe Clear Europe. For the nine months ended September 30, 2026, operating income for the Europe and Asia Pacific segment increased $144.3 million compared to the nine months ended September 30, 2025 primarily due to gain on divestiture, net due to the sale of Cboe Australia, which was completed in July 2026, coupled with an increase in revenues less cost of revenues and a decrease in operating expenses. Operating expenses decreased $33.4 million for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 primarily due to decreases in impairment of Cboe Japan's assets which were impaired in 2025, depreciation and amortization, and technology support services.

Current report

Revenues less cost of revenues decreased $1.4 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 primarily due to a decrease in net transaction and clearing fees as a result of a 7% decrease in ADV. For the three months ended September 30, 2026, operating income for the Futures segment increased $4.9 million compared to the three months ended September 30, 2025 primarily due to a decrease in operating expenses, partially offset by a decrease in revenues less cost of revenues. Operating expenses decreased $6.3 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025 primarily due to decreases in compensation and benefits and professional fees and outside services.
Removed paragraphs (14)

Previous report

The following summarizes changes in financial performance for the three and six months ended June 30, 2026, compared to the three and six months ended June 30, 2025.

Previous report

The following summarizes changes in certain operational and financial metrics for the six months ended June 30, 2026, compared to the six months ended June 30, 2025:

Previous report

Regulatory fees cost of revenues increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in the Section 31 fee rate, from an average rate of $13.24 per million dollars of covered sales for the three months ended June 30, 2025 to an average rate of $19.95 per million dollars of covered sales for the three months ended June 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees cost of revenues decreased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to a decrease in the Section 31 fee rate, from an average rate of $20.52 per million dollars of covered sales for the six months ended June 30, 2025 to an average rate of $9.97 per million dollars of covered sales for the six months ended June 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Previous report

Total operating expenses for the three and six months ended June 30, 2026 compared to the same periods in 2025 increased $7.4 million, or 3%, and $19.4 million, or 4%, respectively, primarily due to an increase in compensation and benefits, partially offset by a decrease in impairment of assets.

Previous report

Technology support services increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to acceleration of certain technology support services as a result of the CEDX wind down.

Previous report

Impairment of assets decreased for the three and six months ended June 30, 2026 compared to the same periods in 2025 primarily due to the impairment of intangible assets charge of $17.1 million related to Cboe Japan during the three and six months ended June 30, 2025.

Previous report

Earnings (loss) on investments, net increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to a $9.5 million increase in the value of the Company's minority equity ownership interest in Eris Innovations as a result of its latest investment round, which the Company did not participate in, a $6.6 million loss recorded during the six months ended June 30, 2025 in the Company's investment in 7Ridge Fund which did not recur in 2026, and a $1.1 million increase in gains from the non-qualified deferred compensation plan.

Previous report

Other income (expense), net increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to foreign transaction gains.

Previous report

Revenues less cost of revenues increased $16.3 million for the three months ended June 30, 2026 compared to the three months ended June 30, 2025 primarily due to a 50% increase in net capture per one hundred touched shares on Cboe U.S. equity exchanges due to pricing changes implemented from late second quarter through the third quarter of 2025, coupled with an increase in access and capacity fees and market data revenue. For the three months ended June 30, 2026, operating income for the North American Equities segment increased $18.8 million compared to the three months ended June 30, 2025 primarily due to an increase in revenues less cost of revenues, coupled with a decrease in operating expenses. Operating expenses decreased $2.5 million for the three months ended June 30, 2026 compared to the three months ended June 30, 2025 primarily due to decreases in professional fees and outside services.

Previous report

Revenues less cost of revenues increased $35.2 million for the six months ended June 30, 2026 compared to the six months ended June 30, 2025 primarily due to an increase in net transaction and clearing fees driven by a 19% increase in Cboe European Equities matched ADNV, coupled with a 22% increase in Cboe Clear Europe net settlement volume. For the six months ended June 30, 2026, operating income for the Europe and Asia Pacific segment increased $54.5 million compared to the six months ended June 30, 2025 primarily due to an increase in revenues less cost of revenues, coupled with a decrease in operating expenses. Operating expenses decreased $19.3 million for the six months ended June 30, 2026 compared to the six months ended June 30, 2025 primarily due to a decrease in impairment of assets.

Previous report

Revenues less cost of revenues increased $0.5 million for the three months ended June 30, 2026 compared to the three months ended June 30, 2025 primarily due to an increase in market data fees. For the three months ended June 30, 2026, operating income for the Futures segment decreased $1.0 million compared to the three months ended June 30, 2025 primarily due to an increase in operating expenses, partially offset by an increase in revenues less cost of revenues. Operating expenses increased $1.5 million for the three months ended June 30, 2026 compared to the three months ended June 30, 2025 primarily due to an increase in travel and promotional expenses and professional fees and outside services.
Reworded paragraphs (92)

Previous wording

Cboe’s subsidiaries include the largest options exchange and the third largest equities exchange operator in the U.S. In addition, the Company operates Cboe Europe Equities (Cboe Europe and Cboe NL equities exchanges), one of the largest equities exchanges by value traded in Europe, and owns Cboe Clear Europe, a leading pan-European clearinghouse, BIDS Holdings, which owns a leading block-trading ATS by volume in the U.S., and provides block-trading services with Cboe market operators in Europe and Canada, Cboe Australia, an operator of a regulated stock exchange in Australia, Cboe Clear U.S., an operator of a regulated clearinghouse, and Cboe Canada, a recognized Canadian securities exchange. Cboe subsidiaries also serve collectively as a leading market globally for exchange-traded products (“ETPs”) listings and trading.

Current wording

Cboe’s subsidiaries include the largest options exchange and the third largest equities exchange operator in the U.S. In addition, the Company operates Cboe Europe Equities (Cboe Europe and Cboe NL equities exchanges), one of the largest equities exchanges by value traded in Europe, and owns Cboe Clear Europe, a leading pan-European equities clearinghouse, BIDS Holdings, which owns a leading block-trading ATS by volume in the U.S. and provides block-trading services with Cboe market operators in Europe and Canada, Cboe Clear U.S., an operator of a regulated clearinghouse, Cboe Canada, a recognized Canadian securities exchange, and Cboe Australia (sold as of July 31, 2026). Cboe subsidiaries also serve collectively as a leading market globally for exchange-traded products (“ETPs”) listings and trading.

Previous wording

The Company is headquartered in Chicago with offices in Amsterdam, Belfast, Hong Kong, Kansas City, London, Manila, New York, Washington D.C., Singapore, Sydney, Tokyo, and Toronto.

Current wording

The Company is headquartered in Chicago with offices in Amsterdam, Belfast, Hong Kong, Kansas City, London, Manila, New York, Washington D.C., Singapore, Tokyo, and Toronto.

Previous wording

In 2025, following a comprehensive strategic review of its global business operations, Cboe initiated the wind down of its Japanese equities business, including the cessation of operations of its Cboe Japan proprietary trading system and Cboe BIDS Japan block trading platform, initiated a sales process for its Cboe Australia and Cboe Canada businesses, discontinued its U.S. and European Corporate Listings efforts, and reduced costs associated with its U.S. and European ETP Listings businesses, Cboe Europe Derivatives ("CEDX"), and several of Cboe’s smaller Risk and Market Analytics businesses.

Current wording

In 2025, following a comprehensive strategic review of its global business operations, Cboe initiated the wind down of its Japanese equities business, including the cessation of operations of its Cboe Japan proprietary trading system and Cboe BIDS Japan block trading platform.

Previous wording

In January 2026, the Company formally initiated the wind down of the CEDX exchange service following a comprehensive strategic review of its global operations. On January 9, 2026, CEDX issued a release to its market participants that Cboe NL is planning to wind down its CEDX exchange service. The CEDX exchange service was decommissioned effective February 23, 2026.

Current wording

In January 2026, the Company formally initiated the wind down of the CEDX exchange service following a comprehensive strategic review of its global operations. The CEDX exchange service was decommissioned effective February 23, 2026.

Previous wording

On April 22, 2026, the Company announced a definitive agreement to sell its Cboe Australia and Cboe Canada businesses to TMX, a leading market operator, for approximately $300 million. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The sales of Cboe Australia and Cboe Canada are expected to close separately, each after required approvals have been obtained. The Company expects the sale of Cboe Australia to close in the third quarter of 2026. Upon closing, the Company will provide transition services support for a limited time.

Current wording

On April 20, 2026, the Company’s Executive Committee of the Board of Directors approved the sale of Cboe Australia and Cboe Canada to a single buyer. On April 22, 2026, the Company announced a definitive agreement to sell its Cboe Australia and Cboe Canada businesses to TMX Group Limited (“TMX”), a leading market operator, for approximately $300 million. The transaction is subject to customary closing conditions, including applicable regulatory approvals. The sale of Cboe Australia closed on July 31, 2026, and the sale of Cboe Canada is expected to close after required approvals have been obtained.

Previous wording

On January 26, 2026, the Company announced the appointments of Scott Johnston as Executive Vice President, Chief Operating Officer, and Heidi Fischer as Executive Vice President, Global Head of Equities and Spot Markets.

Current wording

On January 26, 2026, the Company announced the appointments of Scott Johnston as Executive Vice President, Chief Operating Officer, and Heidi Fischer as Executive Vice President, Head of Cash and Spot Markets.

Previous wording

Options. The Options segment includes options on market indices (“index options”) which include our proprietary SPX and VIX options, as well as on the stocks of individual corporations (“equity options”) and on ETPs such as exchange-traded funds (“ETFs”) and exchange-traded notes (“ETNs”), which are “multi-listed” options and listed on a non-exclusive basis. These options are eligible to trade, as applicable, on Cboe Options, C2, BZX, EDGX, and/or other U.S. national securities exchanges. Cboe Options is the Company’s primary options market and offers trading in listed options through a single system that integrates electronic trading and traditional open outcry trading on the Cboe Options trading floor in Chicago. On June 23, 2026, the Company launched the first products in its new prediction markets suite, Cboe Predicts, a securities-based product that is listed on Cboe Options and centrally cleared by OCC. C2 Options, BZX Options, and EDGX Options are all-electronic options exchanges, and typically operate with different market models and fee structures than Cboe Options. The Options segment also includes applicable market data fees revenues generated from the consolidated tape plans, the licensing of proprietary options market data, index licensing, routing services, and access and capacity services.

Current wording

Options. The Options segment includes options on market indices (“index options”) which include our proprietary SPX and VIX options, as well as on the stocks of individual corporations (“equity options”) and on ETPs such as exchange-traded funds (“ETFs”) and exchange-traded notes (“ETNs”), which are “multi-listed” options and listed on a non-exclusive basis. These options are eligible to trade, as applicable, on Cboe Options, C2, BZX, EDGX, and/or other U.S. national securities exchanges. Cboe Options is the Company’s primary options market and offers trading in listed options through a single system that integrates electronic trading and traditional open outcry trading on the Cboe Options trading floor in Chicago. On June 23, 2026, the Company launched the first products in its new prediction markets suite, Cboe Predicts, a securities-based product that is listed on Cboe Options and centrally cleared by OCC. C2 Options, BZX Options, and EDGX Options are all-electronic options exchanges, and typically operate with different market models and fee structures than Cboe Options. The Options segment also includes applicable market data fee revenues generated from the consolidated tape plans, the licensing of proprietary options market data, index licensing, routing services, and access and capacity services.

Previous wording

Europe and Asia Pacific. The Europe and Asia Pacific segment includes the pan-European derivatives transaction services, ETPs, including exchange traded funds, exchange traded notes, and exchange traded commodities, and international depositary receipts that are hosted on MTFs operated by Cboe Europe Equities (Cboe Europe and Cboe NL equities exchanges) and CEDX. It also includes the ETP listings business on RMs and clearing activities of Cboe Clear Europe, as well as the equities services of Cboe Australia, an operator of a trading venue in Australia. Cboe Europe operates lit and dark books, a periodic auctions book, a closing cross book, and two BIDS order books, a Large-in-Scale (“LIS”) trading negotiation facility and a volume-weighted average price (“VWAP”) trajectory crossing facility. Cboe NL, based in Amsterdam, operates similar business functionality to that offered by Cboe Europe (with the exception of Trajectory Crossing), and provides for trading only in European Economic Area (“EEA”) symbols. In February 2026, Cboe completed the wind down of CEDX, its pan-European derivatives platform that offered futures and options based on Cboe Europe equity indices, FLEX options, and single stock options. Prior to the wind down, CEDX contributed derivatives transaction services to this segment. Cboe Clear Europe offers the clearing of equity and equity-like instruments for Cboe-operated and other regulated trading venues and clearing SFTs. Prior to the CEDX wind down, Cboe Clear Europe also provided clearing services for derivative transactions executed on CEDX. This segment also includes Cboe Europe, Cboe NL, and Cboe Australia revenue generated from the licensing of proprietary market data and from access and capacity services.

Current wording

Europe and Asia Pacific. The Europe and Asia Pacific segment includes the pan-European derivatives transaction services, ETPs, including exchange traded funds, exchange traded notes, and exchange traded commodities, and international depositary receipts that are hosted on MTFs operated by Cboe Europe Equities (Cboe Europe and Cboe NL equities exchanges) and formerly CEDX. It also includes the ETP listings business on RMs and clearing activities of Cboe Clear Europe, as well as the equities services of Cboe Australia, an operator of a trading venue in Australia until July 31, 2026, following the sale of Cboe Australia. Cboe Europe operates lit and dark books, a periodic auctions book, a closing cross book, and two BIDS order books, a Large-in-Scale (“LIS”) trading negotiation facility and a volume-weighted average price (“VWAP”) trajectory crossing facility. Cboe NL, based in Amsterdam, operates similar business functionality to that offered by Cboe Europe (with the exception of Trajectory Crossing), and provides for trading only in European Economic Area (“EEA”) symbols. In February 2026, Cboe completed the wind down of CEDX, its pan-European derivatives platform that offered futures and options based on Cboe Europe equity indices, FLEX options, and single stock options. Prior to the wind down, CEDX contributed derivatives transaction services to this segment. Cboe Clear Europe offers the clearing of equity and equity-like instruments for Cboe-operated and other regulated trading venues and clearing SFTs. Prior to the

Previous wording

•continuing pressure in transaction fee pricing due to intense competition in the North American, European, and Asia Pacific markets;

Current wording

•continuing pressure in transaction fee pricing due to intense competition in the North American and European markets;

Previous wording

Liquidity payments are primarily correlated to the trading volumes on our markets. As stated above, we record the liquidity rebates paid to market participants providing liquidity, in the case of Cboe Options, C2, BZX, EDGX, Cboe Europe Equities and Derivatives, Cboe Clear U.S., Cboe Digital Exchange, and CFE as cost of revenue. BYX offers an inverted pricing model where we rebate liquidity takers for executing against an order resting on our book, which is also recorded as a cost of revenue. EDGA offers a maker-taker fee model under which liquidity providers receive a rebate, while liquidity takers pay a fee, all within a pricing model that does not include volume-based tiers.

Current wording

Liquidity payments are primarily correlated to the trading volumes on our markets. As stated above, we record the liquidity rebates paid to market participants providing liquidity, in the case of Cboe Options, C2, BZX, EDGX, Cboe Europe Equities, Cboe Clear U.S., Cboe Digital Exchange, and CFE as cost of revenue. BYX offers an inverted pricing model where we rebate liquidity takers for executing against an order resting on our book, which is also recorded as a cost of revenue. EDGA offers a maker-taker fee model under which liquidity providers receive a rebate, while liquidity takers pay a fee, all within a pricing model that does not include volume-based tiers.

Previous wording

Other expenses represent costs necessary to support our operations that are not already included in the above categories, including, but not limited to, office expenses, charitable contributions, insurance, and general corporate expenses.

Current wording

Other expenses represent costs necessary to support our operations that are not already included in the above categories, including, but not limited to, bad debt provisions, office expenses, charitable contributions, insurance, and general corporate expenses.

Previous wording

Income and expenses incurred through activities outside of our core operations are considered non-operating and are classified as interest expense, interest income, earnings (loss) on investments, net, or other income (expenses), net. These activities primarily include interest earned on the investing of excess cash, commitment fees and interest expense related to outstanding debt facilities, income and unrealized gains and losses related to investments held in a trust for the Company’s non-qualified retirement and benefit plans, including non-employee director deferred compensation, unrealized and realized gains or losses or income earned related to the Company’s minority investments, exchange gain and loss, and equity earnings or losses from our investments in other business ventures.

Current wording

Income and expenses incurred through activities outside of our core operations are considered non-operating and are classified as interest expense, interest income, earnings (loss) on investments, net, or other income (expenses), net. These activities primarily include interest earned on the investing of excess cash, commitment fees and interest expense related to outstanding debt facilities, income and unrealized gains and losses related to investments held in a trust for the Company’s non-qualified retirement and benefit plans, including non-employee director deferred compensation, unrealized and realized gains or losses or income earned related to the Company’s minority investments, transition services agreement income related to recent divestitures, exchange gain and loss, and equity earnings or losses from our investments in other business ventures.

Previous wording

We believe our presentation of these measures provides additional and comparative information to assess trends in our core operations and a means to evaluate period-to-period comparisons. Non-GAAP financial measures are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results. We have presented the following non-GAAP measures because we consider them important supplemental measures of our performance and believe that they are frequently used by analysts, investors, and other interested parties in the evaluation of companies. We use adjusted operating EBITDA as a measure of operating performance for preparation of our forecasts and we use adjusted EBITDA for evaluating our leverage ratio for the debt to earnings covenant included in our outstanding credit facility. In addition, we have presented adjusted earnings because we consider it an important supplemental measure of our performance and we use it as the basis for monitoring our own core operating financial performance relative to other operators of exchanges. We also believe that it is frequently used by analysts, investors, and other interested parties in the evaluation of companies. We believe that investors may find this non-GAAP measure useful in evaluating our performance compared to that of peer companies in our industry.

Current wording

We believe our presentation of these measures provides additional and comparative information to assess trends in our core operations and a means to evaluate period-to-period comparisons. Non-GAAP financial measures are provided as additional information to investors in order to provide them with an alternative method for assessing our financial condition and operating results. We have presented the following non-GAAP measures because we consider them important supplemental measures of our performance and believe that they are frequently used by analysts, investors, and other interested parties in the evaluation of companies. We use adjusted operating EBITDA as a measure of operating performance for preparation of our forecasts and we use adjusted EBITDA for evaluating our leverage ratio for the debt to earnings covenant included in our outstanding credit facility. In addition, we have presented adjusted earnings because we consider it an important supplemental measure of our performance and we use it as the basis for monitoring our own core operating financial performance relative to other operators of exchanges. We have presented organic net revenue because we consider it a useful measure for evaluating our operating financial performance before the effects of acquisitions or divestitures. We believe that investors may find these non-GAAP measures useful in evaluating our performance compared to that of peer companies in our industry, however, these non-GAAP financial measures are not presented in accordance with, or as an alternative to, GAAP financial measures and may be calculated differently from non-GAAP measures used by other companies, which reduces their usefulness as comparative measures. We encourage analysts, investors, and other interested parties to use these non-GAAP measures as supplemental information to the GAAP financial measures included herein, including our condensed consolidated financial statements, to enhance their analysis and understanding of our performance and in making comparisons. We note that non-GAAP measures have limitations as analytical tools and they should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP. Please see the footnotes below for definitions, additional information, and reconciliations from the closest GAAP measure.

Previous wording

The following summarizes changes in financial performance for the three and six months ended June 30, 2026, compared to the three and six months ended June 30, 2025. “YTD” represents the six month periods ended June 30, 2026 and 2025, respectively:

Current wording

The following summarizes changes in financial performance for the three and nine months ended September 30, 2026, compared to the three and nine months ended September 30, 2025. “YTD” represents the nine month periods ended September 30, 2026 and 2025, respectively:

Previous wording

(1)Adjusted operating income is defined as operating income after relevant operating adjustments, which include revenue, cost of revenues, and operating expense adjustments, as applicable. Adjusted operating margin represents adjusted operating income divided by revenues less cost of revenues. Operating EBITDA is defined as operating income before depreciation and amortization. Operating EBITDA margin represents operating EBITDA divided by revenues less cost of revenues. Adjusted operating EBITDA is calculated by adding back to operating EBITDA relevant operating adjustments, which include revenue, cost of revenues, and operating expense adjustments, as applicable. Adjusted operating EBITDA margin represents adjusted operating EBITDA divided by revenues less cost of revenues. Relevant adjustments are detailed in the reconciliations that follow.

Current wording

(2)Adjusted operating income is defined as operating income after relevant operating adjustments, which include revenue, cost of revenues, operating expense adjustments, and other operating adjustments, as applicable. Adjusted operating margin represents adjusted operating income divided by revenues less cost of revenues. Operating EBITDA is defined as operating income before depreciation and amortization. Operating EBITDA margin represents operating EBITDA divided by revenues less cost of revenues. Adjusted operating EBITDA is calculated by adding back to operating EBITDA relevant operating adjustments, which include revenue, cost of revenues, operating expense adjustments, and other operating adjustments, as applicable. Adjusted operating EBITDA margin represents adjusted operating EBITDA divided by revenues less cost of revenues. Relevant adjustments are detailed in the reconciliations that follow.

Previous wording

(2)EBITDA is defined as income before interest, net, income taxes, and depreciation and amortization. EBITDA margin represents EBITDA divided by revenues less cost of revenues. Adjusted EBITDA is calculated by adding back to EBITDA relevant adjustments, which include revenue, cost of revenues, operating expense, and non-operating adjustments, as applicable. Adjusted EBITDA margin represents adjusted EBITDA divided by revenues less cost of revenues. Adjusted earnings is defined as net income after relevant adjustments, which include revenue, cost of revenues, operating expense, non-operating adjustments, certain tax adjustments, and net income or loss allocated to participating securities, net of income tax effects of these adjustments, as applicable. Adjusted diluted earnings per share represents adjusted earnings divided by diluted weighted average shares outstanding. Relevant adjustments are detailed in the reconciliations that follow.

Current wording

(3)EBITDA is defined as income before interest, net, income taxes, and depreciation and amortization. EBITDA margin represents EBITDA divided by revenues less cost of revenues. Adjusted EBITDA is calculated by adding back to EBITDA relevant adjustments, which include revenue, cost of revenues, operating expense, other operating adjustments, and non-operating adjustments, as applicable. Adjusted EBITDA margin represents adjusted EBITDA divided by revenues less cost of revenues. Adjusted earnings is defined as net income after relevant adjustments, which include revenue, cost of revenues, operating expense, other operating adjustments, non-operating adjustments, certain tax adjustments, and net income or loss allocated to participating securities, net of income tax effects of these adjustments, as applicable. Adjusted diluted earnings per share represents adjusted earnings divided by diluted weighted average shares outstanding. Relevant adjustments are detailed in the reconciliations that follow.

Previous wording

The following is a reconciliation of operating income to adjusted operating income (in millions) for the three and six months ended June 30, 2026 and 2025, respectively:

Current wording

The following is a reconciliation of operating income to adjusted operating income (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively:

Previous wording

The following is a reconciliation of operating income to operating EBITDA and adjusted operating EBITDA by segment (in millions) for the three and six months ended June 30, 2026 and 2025, respectively:

Current wording

The following is a reconciliation of operating income (loss) to operating EBITDA and adjusted operating EBITDA by segment (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively:

Previous wording

The following is a reconciliation of net income (loss) allocated to common stockholders to EBITDA and adjusted EBITDA (in millions) for the three and six months ended June 30, 2026 and 2025, respectively:

Current wording

The following is a reconciliation of net income allocated to common stockholders to EBITDA and adjusted EBITDA (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively:

Previous wording

The following is a reconciliation of net income allocated to common stockholders to adjusted earnings (in millions):

Current wording

The following is a reconciliation of net income allocated to common stockholders to adjusted earnings (in millions) for the three and nine months ended September 30, 2026 and 2025, respectively:

Previous wording

(c) This amount represents certain strategic realignment costs related to announced strategic realignment initiatives. For the three months ended June 30, 2026, the costs included $21.7 million in compensation and benefits, $2.5 million in professional fees and outside services, and $0.1 million in technology support services, partially offset by a reversal of $0.6 million in other expenses, on the condensed consolidated statements of income. For the three months ended June 30, 2025, the costs included $17.1 million in impairment of assets and $0.2 million in compensation and benefits on the condensed consolidated statements of income. For the six months ended June 30, 2026, the costs included $23.3 million in compensation and benefits, $4.0 million in professional fees and outside services, and $1.9 million in technology support services, partially offset by a reversal of $0.4 million in other expenses, on the condensed consolidated statements of income. For the six months ended June 30, 2025, the costs included $17.1 million in impairment of assets and $0.5 million in compensation and benefits on the condensed consolidated statements of income.

Current wording

(e) This amount represents certain strategic realignment costs related to announced strategic realignment initiatives. For the three months ended September 30, 2026, the costs included $13.0 million in compensation and benefits, $2.1 million in professional fees and outside services, $1.4 million in impairment of assets, and $0.2 million in other expenses on the condensed consolidated statements of income. For the three months ended September 30, 2025, the costs included $4.5 million in impairment of assets and $2.5 million in compensation and benefits on the condensed consolidated statements of income. For the nine months ended September 30, 2026, the costs included $36.3 million in compensation and benefits, $6.1 million in professional fees and outside services, $1.9 million in technology support services, and $1.4 million in impairment of assets, partially offset by a reversal of $0.2 million in other expenses on the condensed consolidated statements of income. For the nine months ended September 30, 2025, the costs included $21.6 million in impairment of assets and $3.0 million in compensation and benefits on the condensed consolidated statements of income.

Previous wording

(e) This amount represents net gains and losses associated with the PYTH token intangible assets and the Company's minority investments in Abaxx Singapore Pte, American Financial Exchange, LLC, and Eris Innovations Holdings, LLC, which are included in earnings (loss) on investments, net on the condensed consolidated statements of income.

Current wording

(g) This amount represents gains associated with the Company's former investment in 7Ridge Fund (which owns Trading Technologies) as a result of Trading Technologies' sale, as well as the net gains and losses associated with the Company's minority investments, in addition to PYTH token intangible assets which are included in earnings on investments, net on the condensed consolidated statements of income.

Previous wording

(f) These amounts represent the tax impact related to the resolution of uncertain tax positions for the three and six months ended June 30, 2026 and the remeasurements of deferred tax assets and liabilities at prevailing effective tax rates for the three and six months ended June 30, 2025.

Current wording

(h) These amounts represent the remeasurements of deferred tax assets and liabilities at prevailing effective tax rates for the three and nine months ended September 30, 2026 and 2025, the tax impact related to the resolution of uncertain tax positions and prior year state provision-to-return adjustments for the three and nine months ended September 30, 2026.

Previous wording

The following summarizes changes in certain operational and financial metrics for the six months ended June 30, 2026, compared to the six months ended June 30, 2025 (continued from previous page):

Current wording

The following summarizes changes in certain operational and financial metrics for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025 (continued from previous page):

Previous wording

The following table includes operational and financial metrics for our Options, North American Equities, Europe and Asia Pacific, Futures, and Global FX segments. The following summarizes changes in certain operational and financial metrics for the three and six months ended June 30, 2026 compared to the three and six months ended June 30, 2025:

Current wording

The following table includes operational and financial metrics for our Options, North American Equities, Europe and Asia Pacific, Futures, and Global FX segments. The following summarizes changes in certain operational and financial metrics for the three and nine months ended September 30, 2026 compared to the three and nine months ended September 30, 2025:

Previous wording

(15)Net capture per one million dollars traded refers to net transaction fees less liquidity payments, if any, divided by the product of one-thousandth of ADNV traded on Cboe FX Markets and the number of trading days for Spot and SEF, divided by two, which represents the buyer and seller that are both charged on the transaction.

Current wording

(14)Net capture per one million dollars traded refers to net transaction fees less liquidity payments, if any, divided by the product of one-thousandth of ADNV traded on Cboe FX Markets and the number of trading days for Spot and SEF, divided by two, which represents the buyer and seller that are both charged on the transaction.

Previous wording

Total revenues for the three months ended June 30, 2026 increased $269.3 million, or 23%, compared to the same period in 2025 primarily due to an increase in derivatives markets and cash and spot markets revenue driven by an increase in transaction and clearing fees as a result of increased volumes traded on the Cboe options, Cboe U.S. equities, and Cboe European equities exchanges, coupled with an increase in the Section 31 fee rate following a rate change in April 2026. Total revenues for the six months ended June 30, 2026 increased $347.1 million, or 15%, compared to the same period in 2025 primarily due to an increase in derivatives markets and cash and spot markets revenue driven by an increase in transaction and clearing fees as a result of increased volumes traded on the Cboe options, Cboe U.S. equities, and Cboe European equities exchanges, partially offset by a decrease in the average Section 31 fee rate following a rate change in May 2025, decreasing the rate to $0 per million dollars of covered sales, which remained in effect until April 2026.

Current wording

Total revenues for the three months ended September 30, 2026 increased $217.1 million, or 19%, compared to the same period in 2025 primarily due to an increase in the Section 31 fee rate following a rate change in April 2026, coupled with an increase in derivatives markets revenue driven by an increase in transaction and clearing fees as a result of increased volumes traded on the Cboe options exchanges, partially offset by a decrease in volumes traded on the Cboe U.S. equities exchanges. Total revenues for the nine months ended September 30, 2026 increased $564.2 million, or 16%, compared to the same period in 2025 primarily due to an increase in derivatives markets and cash and spot markets revenue driven by an increase in transaction and clearing fees as a result of increased volumes traded on the Cboe options, Cboe U.S. equities, and Cboe European equities exchanges, coupled with an increase in Section 31 fees due to an increase in volumes traded on the Cboe U.S. equity and options exchanges.

Previous wording

The following summarizes changes in revenues for the three and six months ended June 30, 2026 compared to the three and six months ended June 30, 2025 (in millions, except percentages):

Current wording

The following summarizes changes in revenues for the three and nine months ended September 30, 2026 compared to the three and nine months ended September 30, 2025 (in millions, except percentages):

Previous wording

Cash and spot markets revenue increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in regulatory fees and transaction and clearing fees. Regulatory fees increased primarily due to an increase in the Section 31 fee rate, from an average of $13.24 per million dollars of covered sales for the three months ended June 30, 2025 to an average rate of $19.95 per million dollars of covered sales for the three months ended June 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees. Transaction and clearing fees increased primarily due to pricing changes implemented from late second quarter through the third quarter of 2025 on Cboe U.S. equity exchanges (BZX, BYX, EDGX, and EDGA, collectively, the "Cboe U.S. equity exchanges") and a 13% increase in Cboe European equities exchanges matched ADNV.

Current wording

Cash and spot markets revenue increased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in regulatory fees, partially offset by a decrease in transaction and clearing fees on Cboe U.S. equity exchanges (BZX, BYX, EDGX, EDGA, collectively, the "Cboe U.S. equity exchanges"). Regulatory fees increased primarily due to an increase in the Section 31 fee rate, from an average of $0 per million dollars of covered sales for the three months ended September 30, 2025 to an average rate of $20.60 per million dollars of covered sales for the three months ended September 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees. Transaction and clearing fees decreased primarily due to a 12% decrease in total matched shares on Cboe U.S. equity exchanges.

Previous wording

Cash and spot markets revenue increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, partially offset by a decrease in regulatory fees. Transaction and clearing fees increased primarily due to an 8% increase in total matched shares on Cboe U.S. equity exchanges, a 19% increase in Cboe European equities exchanges matched ADNV, and a 22% increase in Cboe Clear Europe's net settlement volume. Regulatory fees decreased primarily due to a decrease in the Section 31 fee rate, from an average of $20.52 per million dollars of covered sales for the six months ended June 30, 2025 to an average rate of $9.97 per million dollars of covered sales for the six months ended June 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Current wording

Cash and spot markets revenue increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, coupled with an increase in regulatory fees. Transaction and clearing fees increased primarily due to pricing changes implemented from late second quarter through the third quarter of 2025 on Cboe U.S. equity exchanges, a 15% increase in Cboe European equities exchanges matched ADNV, and a 22% increase in Global FX ADNV. Regulatory fees increased primarily due to an increase in the volumes on the Cboe U.S. equity and options exchanges, partially offset by a decrease in the Section 31 fee rate, from an average of $13.68 per million dollars of covered sales for the nine months ended September 30, 2025 to an average rate of $13.52 per million dollars of covered sales for the nine months ended September 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Previous wording

Data Vantage revenue increased for the three and six months ended June 30, 2026 compared to the same periods in 2025 primarily due to increases in access and capacity fees and proprietary market data fees. Access and capacity fees increased primarily due to increases in logical port fees and physical port fees in the Options, North American Equities, and Europe and Asia Pacific segments, driven by increased customer demand. Proprietary market data fees increased primarily due to increases in customer demand for existing data products as a result of increased new unit sales and a strong contribution from new product sales, complementing continued demand for access to our markets and a durable and growing international contribution.

Current wording

Data Vantage revenue increased for the three and nine months ended September 30, 2026 compared to the same periods in 2025 primarily due to increases in access and capacity fees and proprietary market data fees. Access and capacity fees increased primarily due to increases in logical port fees and physical port fees in the Options and North American Equities segments, driven by increased customer demand. Proprietary market data fees increased primarily due to increases in customer demand for existing data products as a result of increased new unit sales and a strong contribution from new product sales, complementing continued demand for access to our markets and a durable and growing international contribution.

Previous wording

Derivatives markets revenue increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, coupled with an increase in regulatory fees. Transaction and clearing fees increased primarily due to a 32% increase in index options ADV and a 24% increase in multi-listed options ADV. Regulatory fees increased primarily due to an increase in the Section 31 fee rate, from an average of $13.24 per million dollars of covered sales for the three months ended June 30, 2025 to an average rate of $19.95 per million dollars of covered sales for the three months ended June 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Current wording

Derivatives markets revenue increased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, coupled with an increase in regulatory fees. Transaction and clearing fees increased primarily due to a 24% increase in index options ADV. Regulatory fees increased primarily due to an increase in the Section 31 fee rate, from an average of $0 per million dollars of covered sales for the three months ended September 30, 2025 to an average rate of $20.60 per million dollars of covered sales for the three months ended September 30, 2026, following a rate change effective April 2026 to $20.60 per million dollars of covered sales. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Previous wording

Derivatives markets revenue increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, partially offset by a decrease in regulatory fees. Transaction and clearing fees increased primarily due to a 31% increase in index options ADV and a 14% increase in multi-listed options ADV. Regulatory fees decreased primarily due to a decrease in the Section 31 fee rate, from an average of $20.52 per million dollars of covered sales for the six months ended June 30, 2025 to an average rate of $9.97 per million dollars of covered sales for the six months ended June 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Current wording

Derivatives markets revenue increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in transaction and clearing fees, coupled with an increase in regulatory fees. Transaction and clearing fees increased primarily due to a 28% increase in index options ADV and a 12% increase in multi-listed options ADV. Regulatory fees increased primarily due to an increase in volumes traded on the Cboe U.S. equity and options exchanges, partially offset by a decrease in the Section 31 fee rate, from an average of $13.68 per million dollars of covered sales for the nine months ended September 30, 2025 to an average rate of $13.52 per million dollars of covered sales for the nine months ended September 30, 2026, following a rate change in May 2025 to $0 per million dollars of covered sales, which remained in effect until April 2026. Regulatory fees revenue related to Section 31 fees is directly offset by regulatory fees cost of revenues related to Section 31 fees.

Previous wording

The following tables reconcile the disaggregated cost of revenues captions presented on the condensed consolidated statements of income to the revenue captions presented on the condensed consolidated statements of income for the three and six months ended June 30, 2026 and 2025, respectively (in millions):

Current wording

The following tables reconcile the disaggregated cost of revenues categories presented on the condensed consolidated statements of income to the revenue categories presented on the condensed consolidated statements of income for the three and nine months ended September 30, 2026 and 2025, respectively (in millions):

Previous wording

Total cost of revenues increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in liquidity payments as a result of an increase in total matched shares on the Cboe U.S. equity exchanges and an increase in royalty fees due to increased volumes on Cboe options exchanges, partially offset by a decrease in regulatory fees cost of revenues as a result of a decrease in the average Section 31 fee rate.

Current wording

Total cost of revenues increased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in regulatory fees cost of revenues as a result of an increase in the Section 31 fee rate, partially offset by a decrease in liquidity payments due to a decrease in total matched shares on Cboe U.S. equity exchanges.

Previous wording

The following summarizes changes in the disaggregated cost of revenues for the three and six months ended June 30, 2026 compared to the three and six months ended June 30, 2025 (in millions, except percentages):

Current wording

The following summarizes changes in the disaggregated cost of revenues for the three and nine months ended September 30, 2026 compared to the three and nine months ended September 30, 2025 (in millions, except percentages):

Previous wording

Liquidity payments increased for the six months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in liquidity payments on the Cboe U.S. equity exchanges as a result of an 8% increase in total matched shares, coupled with an increase in liquidity payments on the Cboe options exchanges as a result of liquidity payments fee tier shifts, largely within multi-listed options.

Current wording

Liquidity payments decreased for the three months ended September 30, 2026 compared to the same period in 2025 primarily due to a decrease in liquidity payments on the Cboe U.S. equity exchanges as a result of a 12% decrease in total matched shares.

Previous wording

Liquidity payments increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in liquidity payments on the Cboe options exchanges as a result of a 24% increase in multi-listed options ADV, coupled with an increase in liquidity payments on the Cboe U.S. equity exchanges primarily due to pricing changes implemented from late second quarter through the third quarter of 2025 on Cboe U.S. equity exchanges.

Current wording

Liquidity payments increased for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in liquidity payments on the Cboe U.S. equity exchanges primarily due to pricing changes implemented in 2025 on Cboe U.S. equity exchanges.

Previous wording

Routing and clearing fees increased for the three and six months ended June 30, 2026 compared to the same periods in 2025 primarily due to 21% and 22% increases in Cboe Clear Europe net settlement volume, respectively, partially offset by a decrease in routed trades on the Cboe U.S. equity exchanges.

Current wording

Routing and clearing fees decreased for the three and nine months ended September 30, 2026 compared to the same periods in 2025 primarily due to a decrease in routed trades on the Cboe U.S. equity exchanges, partially offset by 19% and 21% increases in Cboe Clear Europe net settlement volume, respectively.

Previous wording

Royalty fees and other cost of revenues increased for the three and six months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in trading volumes of index products in the Options segment.

Current wording

Royalty fees and other cost of revenues increased for the three and nine months ended September 30, 2026 compared to the same periods in 2025 primarily due to an increase in trading volumes of index products in the Options segment.

Showing the first 40 of 92 pairs. Open the source sections for the rest.

Rearranged current paragraphs (2)

Current report — wording carried from elsewhere

CEDX wind down, Cboe Clear Europe also provided clearing services for derivative transactions executed on CEDX. This segment also includes Cboe Europe, Cboe NL, and formerly Cboe Australia revenue generated from the licensing of proprietary market data and from access and capacity services.

Current report — wording carried from elsewhere

Revenues less cost of revenues increased $414.7 million, or 24%, for the nine months ended September 30, 2026 compared to the same period in 2025 primarily due to an increase in derivatives markets revenues less cost of revenues driven by an increase in volumes traded on the Cboe options exchanges, an increase in cash and spot markets revenues less cost of revenues driven by increases in net capture per one hundred touched shares on the Cboe U.S. equity exchanges, and an increase in Data Vantage revenues less cost of revenues as a result of increased access and capacity fees and proprietary market data across segments.
Rearranged previous paragraphs (3)

Previous report — wording carried elsewhere

These non-GAAP financial measures are not presented in accordance with, or as an alternative to, GAAP financial measures and may be calculated differently from non-GAAP measures used by other companies, which reduces their usefulness as comparative measures. We encourage analysts, investors, and other interested parties to use these non-GAAP measures as supplemental information to the GAAP financial measures included herein, including our condensed consolidated financial statements, to enhance their analysis and understanding of our performance and in making comparisons. We note that non-GAAP measures have limitations as analytical tools and they should not be considered in isolation or as substitutes for analysis of our results as reported under GAAP. Please see the footnotes below for definitions, additional information, and reconciliations from the closest GAAP measure.

Previous report — wording carried elsewhere

(14)Net capture per matched notional value refers to transaction fees less liquidity payments in Australian dollars divided by the product of ADNV in Australian dollars of shares matched on Cboe Australia and the number of Australian Equities trading days.

Previous report — wording carried elsewhere

Total cost of revenues increased for the three months ended June 30, 2026 compared to the same period in 2025 primarily due to an increase in regulatory fees cost of revenues as a result of an increase in the Section 31 fee rate, coupled with an increase in liquidity payments due to an increase in multi-listed options ADV and pricing changes implemented from late second quarter through the third quarter of 2025 on the Cboe U.S. equity exchanges.